Case Report: Combined Intravenous Infusion and Local Injection of CAR-T Cells Induced Remission in a Relapsed Diffuse Large B-Cell Lymphoma Patient

Relapsed diffuse large B-cell lymphoma (DLBCL) is a disease with a poor prognosis. Recent clinical trials results showed chimeric antigen receptor (CAR) T cell therapy has a promising role in treating relapsed DLBCL. Unfortunately, patients with extranodal lesions respond poorly to CAR-T cells admin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Linhui, Wu, Fan, Wang, Huiping, Zhu, Weiwei, Wang, Juan, Yu, Fengxiang, Zhai, Zhimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092435/
https://www.ncbi.nlm.nih.gov/pubmed/33953727
http://dx.doi.org/10.3389/fimmu.2021.665230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092435/
https://www.ncbi.nlm.nih.gov/pubmed/33953727
http://dx.doi.org/10.3389/fimmu.2021.665230

Ejemplares similares